Brief: PDS Biotech Announces Preliminary Biomarker Study Results In Subset Of Advanced Hpv-Positive Head And Neck Cancer Patients
23/10/2023 13:24
Oct 23 (Reuters) - PDS Biotechnology Corp PDSB.O :
* PDS BIOTECH ANNOUNCES PRELIMINARY BIOMARKER STUDY RESULTS
IN
SUBSET OF ADVANCED HPV-POSITIVE HEAD AND NECK CANCER PATIENTS AT
ESMO
Source text for Eikon: ID:nGNX5npQBV
Further company coverage: PDSB.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on PDS Biotechnology
See all newsPDS Biotechnology Corp reports results for the quarter ended September 30 - Earnings Summary
PDS Biotechnology Q3 net loss narrows on lower R&D costs
PDS Biotechnology Corp expected to post a loss of 10 cents a share - Earnings Preview
Brief: PDS Biotech Announces Initial Closing Of Up To $22.3 Mln PIPE Financing
Brief: Pds Biotechnology Corp - On Aug 6, Approved Reduction In Force To Align Expenses With Strategic Priorities - SEC Filing